NEWS: AEMD UP 110% Rising Again after small pullback.. " Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients PR NewswirPR Newswire•June 18, 2020
" announced today that the U.S. Food and Drug Administration (FDA) has approved a supplement to the Company's existing Investigational Device Exemption (IDE) for the Company's Hemopurifier® in viral disease to allow for the testing of the Hemopurifier in patients with SARS-CoV-2/COVID-19 in a new feasibility study. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.